In contrast, PTEN loss (due to deletion, mutation and/or downregulation), is one of the most frequent mutations in primary PC, and as well, a strong predictor of poor biochemical recurrence and recurrence-free survival [26–28]. This evidence concerns the gene PTEN and pachyonychia congenita.